Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Lexington, USA
99 Hayden Avenue
Suite 390
Lexington, MA, 02421
USA

People

CEO & Board of Directors
Founder
Founder
Founder & Board of Directors
CBO
Vice President of Pharmaceutical Development
Board of Directors
Board of Directors
Show All People

Funding

TOTAL $53.4M
FUNDING TOTAL $53.4M
Series A, 3/2009
Polaris Partners
5AM Ventures
$3.5M
Series B, 11/2009
ARCH Venture Partners
Novartis Venture Fund
Polaris Partners
5AM Ventures
$30.2M
Grant, 12/2010
$5.7M
Series B, 8/2011
Polaris Partners
5AM Ventures
ARCH Venture Partners
Novartis Venture Fund
$14M
DEBT TOTAL $20.5M
Debt, 2/2013
$20.5M

Tags

Pulmatrix

Pulmatrix, Inc., a clinical stage biopharmaceutical company, develops inhaled therapies for the treatment, prevention, and transmission control of infectious and progressive respiratory diseases. It offers inhaled cationic airway lining modulator drugs, which stimulate host defense mechanisms within the airway to treat and prevent influenza, rhinovirus, and chronic pulmonary diseases. The company was founded in 2003 and is based in Lexington, Massachusetts.

Recent Milestones

Videos

Screenshots

Pulmatrix screenshot
Above: Home Page
Uploaded: 1/28/10

Sources

  1. Mass High Tech (masshightech.com) [edit]
  2. Xconomy Boston (xconomy.com) [edit]
  3. Pulmatrix Secures $5.7M Darpa Grant, Hires Eva Jack As CBO (fis.dowjones.com) [edit]
  4. Pulmatrix Secures a $14 million Financing to Advance Clinical Programs in COPD and Cystic Fibrosis (eon.businesswire.com) [edit]
  5. SEC (sec.gov) [edit]
Edit This Page
Last Edited 12/16/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy